Abstract
The issue of bacterial coinfection and superinfections in patients managed for the novel coronavirus disease (COVID-19) has been a matter of concern and debate since the beginning of the COVID-19 pandemic [1]. Incidence, type and etiology of co-infections and super-infections in patients hospitalized for COVID-19 have been reported in several studies, and most of published data have been summarized in two large systematic reviews [2, 3]. The prevalence of superinfections was highest in patients admitted to intensive care unit (ICU) reaching up to 41% [2, 3].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
